TY - JOUR
T1 - Acute traumatic coagulopathy in the setting of isolated traumatic brain injury
T2 - A systematic review and meta-analysis
AU - Epstein, Daniel Joel
AU - Mitra, Biswadev
AU - O'Reilly, Gerard Michael
AU - Rosenfeld, Jeffrey Victor
AU - Cameron, Peter
PY - 2014
Y1 - 2014
N2 - Background and objectives Acute traumatic coagulopathy (ATC) has been reported in the setting of isolated traumatic brain injury (iTBI) and associated with high mortality and poor outcomes. The aim of this systematic review was to examine the incidence and outcome of patients with ATC in the setting of iTBI. Methods We conducted a search of the MEDLINE database and Cochrane library, focused on subject headings and keywords involving coagulopathy and TBI. Design and results of each study were described. Studies were assessed for heterogeneity and the pooled incidence of ATC in the setting of iTBI determined. Reported outcomes were described. Results There were 22 studies selected for analysis. A statistically significant heterogeneity among the studies was observed (p <0.01). Using the random effects model the pooled proportion of patients with ATC in the setting of iTBI was 35.2 (95 CI: 29.0-41.4). Mortality of patients with ATC and iTBI ranged between 17 and 86 . Higher blood transfusion rates, longer hospital stays, longer ICU stays, decreased ventilator free days, higher rates of single and multiple organ failure and higher incidence of delayed injury and disability at discharge were reported among patients with ATC. Conclusions ATC is commonly associated with iTBI and almost uniformly associated with worse outcomes. Any disorder of coagulation above the normal range appears to be associated with worse outcomes and therefore a clinically important target for management. Earlier identification of patients with ATC and iTBI, for recruitment into prospective trials, presents avenues for further research.
AB - Background and objectives Acute traumatic coagulopathy (ATC) has been reported in the setting of isolated traumatic brain injury (iTBI) and associated with high mortality and poor outcomes. The aim of this systematic review was to examine the incidence and outcome of patients with ATC in the setting of iTBI. Methods We conducted a search of the MEDLINE database and Cochrane library, focused on subject headings and keywords involving coagulopathy and TBI. Design and results of each study were described. Studies were assessed for heterogeneity and the pooled incidence of ATC in the setting of iTBI determined. Reported outcomes were described. Results There were 22 studies selected for analysis. A statistically significant heterogeneity among the studies was observed (p <0.01). Using the random effects model the pooled proportion of patients with ATC in the setting of iTBI was 35.2 (95 CI: 29.0-41.4). Mortality of patients with ATC and iTBI ranged between 17 and 86 . Higher blood transfusion rates, longer hospital stays, longer ICU stays, decreased ventilator free days, higher rates of single and multiple organ failure and higher incidence of delayed injury and disability at discharge were reported among patients with ATC. Conclusions ATC is commonly associated with iTBI and almost uniformly associated with worse outcomes. Any disorder of coagulation above the normal range appears to be associated with worse outcomes and therefore a clinically important target for management. Earlier identification of patients with ATC and iTBI, for recruitment into prospective trials, presents avenues for further research.
UR - http://www.sciencedirect.com/science/article/pii/S0020138314000229
U2 - 10.1016/j.injury.2014.01.011
DO - 10.1016/j.injury.2014.01.011
M3 - Article
SN - 0020-1383
VL - 45
SP - 819
EP - 824
JO - Injury
JF - Injury
IS - 5
ER -